To determine the relationship between inhibitor selectivity profile and its ability to block PI3K signalling, we also measured AKT phosphorylation in HCT116 human colorectal cancer cells (Fig. 1a), including additional PI3K pathway inhibitors to widen the analysis. The gene discussed is AKT1; the disease is colorectal cancer.